COLL News and Press, Collegium Pharmaceutical Inc. From 02/27/21

Collegium Pharmaceutical, Inc. (COLL) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference...

Image source: The Motley Fool. Collegium Pharmaceutical Inc (NASDAQ: COLL) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Collegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call Tran...

Collegium Pharmaceutical (COLL): Q4 GAAP EPS of $0.20 misses by $0.11.Revenue of $76.27M (+2.8% Y/Y) misses by $1.16M.Press Release For further details see: Collegium Pharmaceutical EPS misses by $0.11, misses on revenue

– 2020 First Full-Year of Profitability, Driven by Xtampza ® ER Revenue Growth and the Nucynta ® Acquisition – – Collegium Reiterates Previously Issued 2021 Guidance – – Conference Call Scheduled for Today ...

Collegium Pharmaceutical (NASDAQ:COLL) is scheduled to announce Q4 earnings results on Thursday, February 25th, after market close.The consensus EPS Estimate is $0.97 (vs. -$0.07 in year ago quarter) and the consensus Revenue Estimate is $77.43M (+4.4% Y/Y).Over the last 2 years, COLL ha...

STOUGHTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time. The Company will discuss its financial results ...

At times, the reason or reasons behind a stock's rise are obscure or mysterious. But that certainly wasn't the case with Collegium Pharmaceutical (NASDAQ: COLL) on Tuesday, which shot 9.8% higher thanks to a development that should dramatically raise its profile. Collegium, a ...

Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join S&P MidCap 400; Collegium Pharmaceutical to Join S&P SmallCap 600 Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join S&P MidCap 400; Collegium Pharmaceutica...

Monolithic Power Systems (MPWR) is up 2.6% after hours following news that it's moving into the S&P 500. There the company will replace TechnipFMC (FTI), which is being removed from the 500 in anticipation of its announced spin-off of Technip Energies likely to wrap next week. Iridium Com...

Collegium Pharmaceutical (COLL) provides its FY2021 guidance as follows:Xtampza ER revenues expected to be in the range of $155-$165MNucynta franchise revenues in the range of $175-$185M.Adj. EBITDA (excluding stock-based compensation) is expected in the range of $160-$170M.Tot...